Isospec is a Swiss techbio commercialising CIRIS, a proprietary platform for unambiguous structural identification of unknown metabolites, lipids and glycans, with applications in biomarker discovery and biologics bioprocess development. Generating CRO revenue with first pharma R&D customers, Isospec is building proprietary multi-omics data assets through a hospital network to leverage its exclusive metabolome coverage in training models to predict treatment response and disease progression.

Isospec Analytics

Isospec Analytics